PTGDR and breast carcinoma: The results of our experiment (Figure 4d) show that the knock-down of UGGT1-AS1 increased cell proliferation in MCF7 breast cancer cells compared to cells treated with negative control GapmeRs, suggesting that UGGT1-AS1 may play an inhibitory role in cell proliferation in the studied breast cancer cell line.